Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Chronic disease management stories

Oct 27, 2026

Study finds long-acting cabotegravir and rilpivirine maintains HIV viral suppression

Research presented at IDWeek shows that long-acting injectable antiretroviral therapy combining cabotegravir and rilpivirine consistently maintains virologic suppression in adults with HIV who were previously virologically suppressed. The real-world study addresses questions about the effectiveness of switching from oral to injectable ART.

Oct 27, 2026·2 sources
00
Oct 23, 2026

CVS Health pilots pharmacist-led chronic disease management program across retail stores

CVS Health is testing an expanded role for pharmacists in its 9,000 retail stores to help manage chronic diseases and improve healthcare affordability and access, according to Chief Medical Officer Dr. Amy Compton-Phillips. The pilot program would have pharmacists help consumers monitor key health metrics.

Oct 23, 2026·4 sources
00
Oct 22, 2026

Fruits and vegetables outperform sodium bicarbonate for treating metabolic acidosis in chronic kidney disease

A recent clinical trial found that dietary acid reduction using base-producing fruits and vegetables is more effective than the standard oral sodium bicarbonate treatment for metabolic acidosis in people with chronic kidney disease. The findings will be presented at ASN Kidney Week.

Oct 22, 2026·3 sources
00
Oct 20, 2026

FDA approves GSK's hepatitis B drug Hibsago

The FDA approved GSK's hepatitis B drug Hibsago, allowing patients with the liver infection to maintain viral control after stopping long-term treatment. The approval offers a new treatment option for chronic hepatitis B patients.

Oct 20, 2026·2 sources
00

ARCTIC trial shows excellent 10-year outcomes with treat-to-target strategy in early rheumatoid arthritis

A new study from the ARCTIC trial demonstrates that patients with early rheumatoid arthritis managed with a treat-to-target strategy achieved favorable long-term outcomes over 10 years. Patients who achieved sustained remission at two years showed higher remission rates and better physical function throughout the decade-long follow-up period.

Oct 20, 2026·2 sources
00
May 28, 2026

GSK's Experimental Hepatitis B Drug Achieves Functional Cure in Nearly 1 in 5 Patients in Late-Stage Trials

GSK reported that its experimental chronic hepatitis B drug helped nearly one in five patients achieve a functional cure in late-stage studies, vastly outpacing current treatments and raising hopes for a finite treatment course as an alternative to lifelong therapy.

May 28, 2026·2 sources
00
May 8, 2026

Healthcare Leaders Emphasize Trust as Critical Factor in AI Adoption Amid Industry Implementation Challenges

Singapore Health Minister Ong Ye Kung and healthcare industry experts highlight that public distrust poses a fundamental barrier to AI adoption in healthcare, as the sector continues to lag behind other industries in implementation despite initiatives like Singapore's SIMFONI AI model for chronic disease management.

May 8, 2026·5 sources
00

Top claims

  • ▪An OPERA cohort study of 7,995 HIV-positive adults presented by Dr. Ricky Hsu at IDWeek in October 2026 demonstrated that long-acting cabotegravir and rilpivirine maintained virologic suppression.
  • ▪Discontinuations of long-acting cabotegravir and rilpivirine in the OPERA study were infrequently caused by injection-site reactions or lack of efficacy, resulting more often from logistical and insurance challenges.
  • ▪The FDA approved long-acting cabotegravir and rilpivirine in 2021 as a complete injectable antiretroviral therapy alternative to daily oral HIV treatment.

Subtopics

Antiviral therapy2Clinical trials2Drug Approval and Clinical Trials2Drug Policy, Pricing & Approval2Hepatitis B treatment2AI in healthcare1AI regulation & lawsuits1Autoimmune disease1Autoimmune disease treatments1Chronic condition monitoring1Chronic conditions1Chronic disease1Clinical evaluation1Clinical Trial Design & Evaluation1Dietary interventions1Drug development1FDA drug approval1FDA regulatory approval1Food as medicine1Healthcare access1Healthcare Access and Insurance1Healthcare affordability1Healthcare industry1Healthcare providers1

Related timelines

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories

Strait of Hormuz blockage

148 stories